As shown in Figure 4c,d, the tumor weights of DLD-1 and HT-29 xenografts treated with a combination of Epo+LFM-A13 were significantly lower compared with the control (p < 0.001 and p < 0.01, respectively). Here, EPO is linked to neoplasm.